INSIGHTS ON DRUG DEVELOPMENT
-
Overcoming Excipient Risks And Challenges For Parenteral Formulations
Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.
-
Method Development For Forced Degradation Of GLP-1 Agonist
Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.
-
Leveraging Inductively Coupled Plasma Mass Spectrometry
Explore how utilizing ICP-MS can help pharmaceutical companies ensure the safety and effectiveness of their products, ultimately benefiting both patients and the industry as a whole.
-
T3P – A Green Solution For Peptide Coupling, Water Removal Reactions
The session focuses on the use of T3P (propanephosphonic acid anhydride) in amidation and peptide coupling reactions, including both liquid-phase and solid-phase peptide synthesis.
-
Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety9/16/2025
Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.
-
API In Capsule Vs. The Lost Art Of Formulation Development11/5/2025
API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.
-
Rapid Walkaway Solution For Assessing Viability In Cancer Organoids3/31/2025
Assess anti-cancer compounds' effects on organoid size and morphology with colorectal cancer organoids as well as discover automated imaging and viability assays to streamline drug screening and aid early identification.
-
Navigating Preclinical Drug Development Challenges With Lipid-Based Formulations3/20/2026
Maximize the oral bioavailability of challenging small-molecule candidates and streamline the path from preclinical toxicology to clinical trials by leveraging optimized lipid-based formulations.
-
Democratizing Organ-On-A-Chip Technology4/22/2024
Learn about drug development challenges, the evolution of in vitro cell culture towards greater human relevance, a complete solution for creating human-relevant and translatable models, and more.
DRUG DEVELOPMENT SOLUTIONS
-
Leica DM500 Binocular
Supports a Student Friendly Classroom Environment For Life Science Courses
The Leica DM500 microscope with “plug and play” capability is the ideal tool to make teaching entry-level college and university Life Science courses easy and fun for the instructor and the student.
Student-friendly features such as the pre-focused, pre-centered condenser and the EZTube™ preset diopter, which prevent incorrect adjustments, provide more time for hands-on teaching.
EZStore™ design with integrated handle and cord wrap allows easy carrying, easy lifting and protection against microscope component damage.
-
Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.
-
Enhance your protein production with a next-generation feed specifically designed to boost the performance of CHO-K1 GS cell lines.
-
Explore our full range of products, each backed by rigorous quality control and regulatory compliance, to find the right solution for your pharmaceutical needs.
-
- Enables sample recovery
- Avoids dilution effects
- Analyzes samples in a matrix-free environment
- Has minimal buffer constraints